U.S. stock futures have vacillated during the final session of what’s been a frantic week.
The optimists, who think U.S President Trump’s swift tariff U-turn on Wednesday signaled the peak of trade-war angst has passed, were for a while in ascendance.
But recent market action has shown that the pessimists, who fret that the 90-day tariff pause just prolongs uncertainty — and because of the 145% levy on China at a much higher overall tariff rate, too — are always lurking in the wings.
But, hey, financial markets are built on different opinions. That’s why trades occur.
It’s quite unusual, though, to have opposite viewpoints from the same finance house. On Thursday, we noted that UBS strategist Bhanu Baweja was advising investors to sell any rallies until more is known about how much tariffs will hurt the economy, and adding that it’s possible the S&P 500 SPX could slip below 5,000.
However, in a note published Friday, a team of analysts at UBS Global Wealth Management, led by chief investment officer Mark Haefele, have upgraded U.S. equities to attractive, giving three main reasons for doing so.
First, they reckon that Trump’s pause on what he calls reciprocal tariffs has reduced extreme economic and market risks. Despite China’s tariffs going up to 145%, the move “demonstrated willingness from the Trump administration to change its stance in response to equity and bond market turbulence indicates some sensitivity to market stress, and points to the existence of a ‘Trump put’ in some form,” UBS GWM says.
Next, they believe that news flow is likely to improve. Yes, they are wary that the spat with China may dislocate supply chains, and that the possibility — discussed by Treasury Scott Bessent — of Chinese companies being delisted from U.S. stock exchanges would damage sentiment. But with many countries indicating a desire to negotiate trade, there should be a variety of deals the administration will be keen to promote.
“We believe that progress on negotiations should provide encouragement for investors to look through near-term tariff-induced economic weakness and toward a return to earnings growth in 2026,” say the UBS GWM team.